title: CRISPR/Cas-mediated genome editing to treat EGFR-mutant lung cancer: a personalized molecular surgical therapy.
authors.affiliation: Department of Cardiothoracic Surgery, Division of Thoracic Surgery, Stanford University School of Medicine, Stanford, CA, USA VA Palo Alto Healthcare System, Palo Alto, CA, USA.
authors.forename: Huibin
authors.initials: H
authors.lastname: Tang
authors.affiliation: Department of Cardiothoracic Surgery, Division of Thoracic Surgery, Stanford University School of Medicine, Stanford, CA, USA VA Palo Alto Healthcare System, Palo Alto, CA, USA.
authors.forename: Joseph B
authors.initials: JB
authors.lastname: Shrager
mesh_terms: D064113:CRISPR-Cas Systems; D066246:ErbB Receptors / Q000235:genetics; D018390:Gene Targeting / Q000379:methods*; D006801:Humans; D008175:Lung Neoplasms / Q000628:therapy*; D062346:Molecular Medicine / Q000379:methods*; D057285:Precision Medicine / Q000379:methods*
chemical_list: C512478:EGFR protein, human; D066246:ErbB Receptors